Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients. The four-drug combination ...
15 minutes ago
0
0
Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States. While scientists continue searching for new therapies, advances can also come from understanding ...
1 hour ago
0
1
As the U.S. Drug Enforcement Administration (DEA) gears up for its administrative hearing on the fate of federal marijuana legalization, UNLV Cannabis Policy Institute (CPI) director Riana Durrett offers a rundown on decades ...
10 hours ago
0
4
Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye. Although scientists know some of the structural changes that ensue as this ...
22 hours ago
0
16
West Nile virus (WNV) is transmitted by mosquitoes and is increasingly relevant for Europe and worldwide. It can cause severe brain infection and death, yet there is no specific antiviral treatment or approved human vaccine. ...
23 hours ago
0
1
Many of us would like to keep our brains sharp as we get older. That has helped create a growing market for "brain-health" supplements. These include fish oil capsules and postbiotics, the beneficial, nonliving compounds ...
Jun 22, 2026
0
3
A patent-pending innovation created and validated in Purdue University's College of Engineering could strengthen pharmaceutical research and development in the areas of batch verification, encapsulation efficiency screening ...
Jun 22, 2026
0
2
For many people, the thought of a tasty burger or a cold pint of beer conjures a vivid mental image and drives behavior. This link between thinking and doing serves a clear function—it motivates us to get the necessities ...
Jun 22, 2026
0
74
Research shows that patients who see multiple doctors for high-risk medicines face increased risks of dependence, overdose and death, as well as reduced continuity of care.
Jun 22, 2026
0
3
A new study finds that a class of oral and intranasal medications known as gepants may be an effective and well-tolerated treatment for vestibular migraine (VM). The findings are published in the journal Otolaryngology–Head ...
Jun 21, 2026
0
7
